metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology
Información de la revista
Número
Vol. 29. Núm. 3.
(mayo - junio 2024)
Editorial board
Ann Hepatol. 2024;29:101504
Acceso a texto completo
Editorial
The 2023 meeting of the Latin American Association for the Study of the Liver: A summary and looking ahead
Francisco Javier Valentin-Cortez, Norberto Chávez-Tapia
Ann Hepatol. 2024;29:101476
Acceso a texto completo
Opinions
Liver rupture in patients with amyloidosis: Clinical features and treatment
Xiangyu Du, Liangzhi Wen, Bin Wang, Dongfeng Chen, Wei Wang
Ann Hepatol. 2024;29:101500
Acceso a texto completo
Concise reviews
Pathophysiology of ascites: The importance of the intestine. A surgical contribution to the understanding of a medical problem
Gabriel E. Gondolesi, Carolina Rumbo, Leonardo Montes, Lucia Novellis, Diego Ramisch, Ariel Riquelme Henríquez, Mariana Ortega, Federico Viano, ... Héctor Solar
Ann Hepatol. 2024;29:101498
Acceso a texto completo
Original articles
Gradual dosing of ursodeoxycholic acid in mothers with intrahepatic cholestasis of pregnancy may improve composite neonatal outcome
Amir Hamud, Matan J. Cohen, Drorith Hochner-Celnikier, Benjamin Bar-Oz, Zvi Ackerman
Ann Hepatol. 2024;29:101490
Acceso a texto completo
Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: An updated meta-analysis
Wasit Wongtrakul, Natthinee Charatcharoenwitthaya, Phunchai Charatcharoenwitthaya
Ann Hepatol. 2024;29:101288
Acceso a texto completo
Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
Ana Barreira-Díaz, Mar Riveiro-Barciela, Eva María Fernández-Bonilla, Vanesa Bernal, Agustín Castiella, Marta Casado-Martín, Carolina Delgado, María-Carlota Londoño, ... Magdalena Salcedo
Ann Hepatol. 2024;29:101489
Acceso a texto completo
Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis
Koos de Wit, Diederick J. van Doorn, Bregje Mol, Lonneke A. van Vught, Frederik Nevens, Ulrich Beuers, Cyriel Y. Ponsioen, Charlotte E. Teunissen, R. Bart Takkenberg
Ann Hepatol. 2024;29:101496
Acceso a texto completo
Influence of socioeconomic factors on liver transplant survival outcomes in patients with autoimmune liver disease in the United States
Leandro Sierra, Ana Marenco-Flores, Romelia Barba, Daniela Goyes, Bryan Ferrigno, Wilfor Diaz, Esli Medina-Morales, Behnam Saberi, ... Alan Bonder
Ann Hepatol. 2024;29:101283
Acceso a texto completo
Societal costs and survival of patients with biopsy-verified non-alcoholic steatohepatitis: Danish nationwide register-based study
Jan Håkon Rudolfsen, Lise Lotte Gluud, Henning Grønbæk, Majken K. Jensen, Mogens Vyberg, Jens Olsen, Peter Bo Poulsen, Nanna Hovelsø, ... Peter Jepsen
Ann Hepatol. 2024;29:101285
Acceso a texto completo
Development and validation of a noninvasive prediction model for significant hepatic liver fibrosis in Chinese patients with autoimmune hepatitis
Hanzhu Chen, Wenya Ren, Xingdi Yang, Piao Hu, Shouhao Wang, Chengan Xu, Fei Lv, Yue Zhao, ... Hongying Pan
Ann Hepatol. 2024;29:101287
Acceso a texto completo
Dietary macro and micronutrients associated with MASLD: Analysis of a national US cohort database
Mary Nemer, Fauzia Osman, Adnan Said
Ann Hepatol. 2024;29:101491
Acceso a texto completo
Letters to the editor
Impact of new fatty liver disease nomenclature on primary care— cerebration of gastroenterologists in a regional tertiary care hospital
Xingcen Chen, Deliang Liu, Rong Li
Ann Hepatol. 2024;29:101486
Acceso a texto completo
Prevalence and mortality prognosis of steatotic liver disease phenotypes
Zhiyu Sun, Chi Zhou, Yiwen Zhang, Pengfei Li, Junjie Guo, Zhexun Lian, Hongwei Ji
Ann Hepatol. 2024;29:101487
Acceso a texto completo
MASLD identifies patients with significant hepatic fibrosis and steatosis in fatty liver population
You Deng, Wenya Chen, Wen Xie
Ann Hepatol. 2024;29:101488
Acceso a texto completo
Hot topics in hepatology: a multinational perspective
The burden of liver disease in Latin America
Luis Antonio Díaz, Marcela Villota-Rivas, Francisco Barrera, Jeffrey V. Lazarus, Marco Arrese
Ann Hepatol. 2024;29:101175
Acceso a texto completo
From evidence to clinical practice: Bridging the gap of new liver cancer therapies in Latin America.
Federico Piñero, Ezequiel Mauro, Paola Casciato, Alejandro Forner
Ann Hepatol. 2024;29:101185
Acceso a texto completo
Occult liver disease: A multinational perspective
Paulina Vidal-Cevallos, Nayelli Flores-García, Norberto C. Chávez-Tapia, Naga P. Chalasani
Ann Hepatol. 2024;29:101480
Acceso a texto completo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos